10
29th CINP World
Congress 2014
Brief biography of Plenary Speakers
wednesday, 25 June 2014
14:00 – 14:45
PL-06
e
Plenary Lecture
Optical deconstruction of fully-assembled biological systems
Karl Deisseroth, USA
Karl Deisseroth is the D.H. Chen Professor of Bioengineering and Psychiatry at Stanford University.
He earned his A.B. from Harvard and M.D./Ph.D. from Stanford, serves as Director of Undergraduate
Education in Bioengineering at Stanford, and is a practicing psychiatrist board-certified by the
American Board of Psychiatry and Neurology. He has developed and applied novel technologies for
controlling (optogenetics) and imaging (CLARITY) specific elements within intact biological systems,
and continues to develop and apply new technologies to study physiology and behavior in health and
disease, as well as train researchers around the world. He has received the NIH Pioneer Award
(2005), Scheutze Prize (2008), Society for Neuroscience Young Investigator Award (2009), Koetser
Prize (2010), Nakasone Prize (2010), Spencer Prize (2011), UNC/Perl Prize (2012), Zuelch Prize
(2012), Pasarow Prize (2013), BRAIN prize (2013) and Lounsbery Prize (2013). Deisseroth is a member
of the Institute of Medicine and the National Academy of Sciences.
thursday, 26 June 2014
11:15 – 12:00
PL-07
e
CINP/CCNP Lecture
Interactions between neurotransmitters: The key to remission for depression
Pierre Blier, Canada
Dr. Blier is a Full Professor of the Departments of Psychiatry and Cellular & Molecular Medicine, at
the University of Ottawa, and Director of the Mood Disorders Research Program at the University of
Ottawa Institute of Mental Health Research, Royal Ottawa Mental Health Care Center.
Dr. Blier is on the editorial boards of nine journals, the field editor for Translational Medicine for
International Journal of Neuropsychopharmacology, and the Editor for the Americas of the Journal
of Psychopharmacology. Has published over 450 abstracts and 270 peer-reviewed articles (h factor
of 62) and has given lectures worldwide. He has a basic research laboratory investigating mecha-
nisms of action of psychotropic medications, carries out investigator-initiated clinical studies, and
treats patients with mood and anxiety disorders on a daily basis.
Dr. Blier has received several awards including the Canada Research Chair in Psychopharmacology
(2004-2018) from the Government of Canada and the biennial CINP Basic Research Award in 2010.
Karl Deisseroth
Pierre Blier
